Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07194616

Rectal Cancer CTC Trial

Led by University Hospital Ostrava · Updated on 2025-09-26

120

Participants Needed

4

Research Sites

156 weeks

Total Duration

On this page

Sponsors

U

University Hospital Ostrava

Lead Sponsor

P

Palacky University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This prospective, multi-centre, randomised clinical trial aims to compare the effect of neoadjuvant chemoradiotherapy versus primary surgery on circulating tumor cells (CTCs) in patients with stage II-III rectal cancer without circumferential resection mar-gin involvement. CTCs are considered a promising biomarker for disease dissemination and treatment response. Patients will be randomized to either primary surgical resection with total mesorectal excision or long-course neoadjuvant chemoradiotherapy followed by surgery. Serial blood samples will be collected at predefined time points to assess the presence and dynamics of CTCs. Secondary endpoints include perioperative morbidity and mortality, local recurrence rate, disease-free survival, and overall survival. The results of this study may provide new insights into the prognostic role of CTCs and contribute to optimising treatment strategies for rectal cancer.

CONDITIONS

Official Title

Rectal Cancer CTC Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 63; 18 years
  • Histologically confirmed rectal adenocarcinoma within 12 cm from anal verge
  • Stage II (cT3-4 N0 M0) or stage III (cT1-4 N1-2, M0)
  • Negative circumferential resection margin on staging MRI
  • ASA physical status I-III
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Tumor infiltration beyond fascia recti propria on MRI
  • Metastatic disease (stage IV)
  • Recurrent rectal cancer
  • Other concurrent malignancies
  • Emergency surgery required
  • Contraindication to surgery under general anesthesia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

University Hospital Olomouc

Olomouc, Czechia, 779 00

Actively Recruiting

2

Palacky University Olomouc, Faculty of Medicine

Olomouc, Czechia

Actively Recruiting

3

University Hospital Ostrava

Ostrava, Czechia, 70852

Actively Recruiting

4

Municipal Hospital Ostrava - Fifejdy

Ostrava, Czechia, 728 80

Actively Recruiting

Loading map...

Research Team

J

Jiří Hynčica

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here